Kiromic BioPharma Investor Presentation Deck
May 2023, 25 slides
  1. Kiromic BioPharma
  2. Related Decks
  3. Investor Presentation Decks
| Kiromic BioPharma
forward looking statements | Kiromic BioPharma
contents | Kiromic BioPharma
the difference is the only cell therapy company combining driven genetically edited gamma delta cells with proprietary targeting technology to address solid malignancies diamond neural network gamma delta cell platform solid malignancies in house manufacturing driven | Kiromic BioPharma
strategic competitive landscape | Kiromic BioPharma
solid malignancy market opportunity billion | Kiromic BioPharma
competitive difference a | Kiromic BioPharma
contents oiled | Kiromic BioPharma
artificial intelligence and analytic discovery development platform neural network | Kiromic BioPharma
the difference diamond target discovery platform i | Kiromic BioPharma
contents oiled | Kiromic BioPharma
cell therapy multiple potential indications non viral non non viral non engineered engineered off the shelf off the shelf product product candidate candidate targeting stress targeting stress on on cancer cells cancer cells | Kiromic BioPharma
gamma delta cells guardians of the immune system off the shelf innate potent and safe commercially viable | Kiromic BioPharma
non viral gamma delta cell development | Kiromic BioPharma
cell therapy mechanism of action targeting unique identifiers on tumor tissues | Kiromic BioPharma
cell therapy strong efficacy cell therapy strong safety | Kiromic BioPharma
pipeline | Kiromic BioPharma
in house manufacturing creates risked value par and | Kiromic BioPharma
contents oiled | Kiromic BioPharma
upcoming milestones authorization to evaluate in non small cell lung cancer may beginning of first in human trial activation for data results from first patient in clinical trial by end of initiation of clinical trials expansion cohort submission of new for and | Kiromic BioPharma
leadership team a university | Kiromic BioPharma
board of directors | Kiromic BioPharma
summary balance sheet cap table | Kiromic BioPharma
value proposition summary diamond neural network gamma delta car cell therapy platform off the shelf cellular therapy solid malignancies in house manufacturing i | Kiromic BioPharma
| Kiromic BioPharma
See More
Kiromic BioPharma
Investor Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Cancer
Diamond
Manufacturing
Allogeneic
Tumor
Clinical trial
Artificial intelligence
Related decks
Mink Therapeutics
IPO
October 2021
BioNTech
Results
May 2021
Fusion Pharmaceuticals
IPO
June 2020
BioNTech
Results
November 2021
Immix Biopharma
Investor Presentation
November 2023
Nuvalent
Investor Presentation
January 2024
Immix Biopharma
Investor Presentation
November 2023
Immix Biopharma
Investor Presentation
August 2023
Mink Therapeutics
IPO
October 2021
BioNTech
Results
May 2021
Fusion Pharmaceuticals
IPO
June 2020
BioNTech
Results
November 2021
Immix Biopharma
Investor Presentation
November 2023
Nuvalent
Investor Presentation
January 2024
Immix Biopharma
Investor Presentation
November 2023
Immix Biopharma
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights